Search

Your search keyword '"Lebouvier, T."' showing total 241 results

Search Constraints

Start Over You searched for: Author "Lebouvier, T." Remove constraint Author: "Lebouvier, T."
241 results on '"Lebouvier, T."'

Search Results

5. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)

7. Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia

8. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

9. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

11. Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey

12. L‐DOPA‐induced dyskinesias, motor fluctuations and health‐related quality of life: the COPARK survey

14. ESICM LIVES 2016: part two: Milan, Italy. 1–5 October 2016

16. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimerʼs and Parkinsonʼs diseases

17. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

18. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

19. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

20. Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey

21. Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey

22. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

23. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

26. Que savons-nous de la toxicité récréative du protoxyde d’azote ? Une réponse des Hauts-de-France

27. Correction to:A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

28. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

29. Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

40. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

41. Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

42. Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

43. Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers

45. CXCR4involvement in neurodegenerative diseases

47. Genetic risk for neurodegenerative disorders, and its overlap with cognitive ability and physical function

48. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

49. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer’s and Parkinson’s diseases

50. Intracerebral hemorrhage in ICU: is it worth treating?

Catalog

Books, media, physical & digital resources